Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Gastrointestinal, Hepatic and Biliary Sequelae of Frequent Ketamine Use: a Prospective Observational Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02165488

Organisation Name: The University of Hong Kong

Overal Status: Completed

Start Date: June 2014

Last Update: March 25, 2020

Lead Sponsor: The University of Hong Kong

Brief Summary: 30% of ketamine users complain of abdominal discomfort. Long-term ketamine use is associated with hepatotoxicity and pathologic changes to the biliary tract. Yet the prevalence of gastrointestinal and hepatobiliary pathologies in ketamine users has not been well-described. The investigators plan to recruit a large number of ketamine users based on referrals from different Psychiatry clusters in Hong Kong and to investigate the underlying cause of abdominal discomfort, describe the prevalence of different gastrointestinal and hepatobiliary pathologies and describe their long-term outcome.

Conditions:
  • Gastritis
  • Peptic Ulcer Disease
  • Cholangiopathy
  • Liver Fibrosis


Total execution time in seconds: 0.1972599029541